ATE50433T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE50433T1
ATE50433T1 AT86301656T AT86301656T ATE50433T1 AT E50433 T1 ATE50433 T1 AT E50433T1 AT 86301656 T AT86301656 T AT 86301656T AT 86301656 T AT86301656 T AT 86301656T AT E50433 T1 ATE50433 T1 AT E50433T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
gamma
administration
linolenic acid
acid
Prior art date
Application number
AT86301656T
Other languages
English (en)
Inventor
David Frederick Horrobin
Meadows
Mehar Singh Manku
Sheng Y Efamol Research Huang
P O Box Park
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Application granted granted Critical
Publication of ATE50433T1 publication Critical patent/ATE50433T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86301656T 1985-03-19 1986-03-07 Pharmazeutische zusammensetzungen. ATE50433T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858507058A GB8507058D0 (en) 1985-03-19 1985-03-19 Pharmaceutical & dietary compositions
EP86301656A EP0195570B1 (de) 1985-03-19 1986-03-07 Pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE50433T1 true ATE50433T1 (de) 1990-03-15

Family

ID=10576225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86301656T ATE50433T1 (de) 1985-03-19 1986-03-07 Pharmazeutische zusammensetzungen.

Country Status (10)

Country Link
US (1) US4666701A (de)
EP (1) EP0195570B1 (de)
JP (1) JPS61215322A (de)
AT (1) ATE50433T1 (de)
AU (1) AU584685B2 (de)
CA (1) CA1261274A (de)
DE (1) DE3669064D1 (de)
GB (1) GB8507058D0 (de)
IE (1) IE58712B1 (de)
ZA (1) ZA861774B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278809B1 (de) * 1987-01-19 1992-03-25 Parfums Rochas Kosmetische oder dermatologische Präparate, die einen Extrakt der Früchte des Silybum marianum mit hohem Sylimaringehalt zusammen mit essentiellen Fettsäuren enthalten
GB8705459D0 (en) * 1987-03-09 1987-04-15 Efamol Ltd Treatment of peptic ulcers
US4843095A (en) * 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
DE3920679A1 (de) * 1989-06-23 1991-01-10 Milupa Ag Fettmischung zur herstellung von nahrungen, insbesondere saeuglingsnahrungen
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions
ATE200619T1 (de) * 1991-01-24 2001-05-15 Martek Corp Mikrobielle öle und ihre verwendungen
FR2679109B1 (fr) * 1991-07-18 1994-03-11 Institut Recherche Biologique Sa Nouveaux complements nutritionnels ou dietetiques anti-vieillissement a base d'acide gras poly-insature.
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
US5409955A (en) * 1993-05-13 1995-04-25 Bockow; Barry I. Compositions and methods for inhibiting uterine contractility
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US20020002154A1 (en) * 1998-02-11 2002-01-03 Pol-Henri Guivarc'h Method and composition for treatment of inflammatory conditions
ES2302373T3 (es) * 1998-02-13 2008-07-01 Nutramax Laboratories, Inc. Agentes y metodos para la proteccion, tratamiento y reparacion de tejidos conectivos.
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US6677145B2 (en) 1998-09-02 2004-01-13 Abbott Laboratories Elongase genes and uses thereof
US20030163845A1 (en) * 1998-09-02 2003-08-28 Pradip Mukerji Elongase genes and uses thereof
US6274176B1 (en) * 1999-07-01 2001-08-14 Chromak Research, Inc. Herbal compositions and their use as anti-inflammatory agents for alleviation of arthritis and gout
US7070970B2 (en) 1999-08-23 2006-07-04 Abbott Laboratories Elongase genes and uses thereof
CN1202068C (zh) 2000-02-16 2005-05-18 布里格姆及妇女医院股份有限公司 阿司匹林触发的脂质介体
EP1197550A3 (de) * 2000-08-25 2002-11-20 Pfizer Products Inc. Methoden und Zusammensetzungen zur Diagnose unde Behandlung von Krankheiten an denen Angiogenese beteiligt ist
US6635451B2 (en) * 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
US7045683B2 (en) * 2001-05-04 2006-05-16 Abbott Laboratories Δ4-desaturase genes and uses thereof
GB0111282D0 (en) * 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids
JP2004536059A (ja) * 2001-05-14 2004-12-02 マーテック バイオサイエンシズ ボールダー コーポレーション 微生物、遺伝的に改変された植物種子および海洋生物由来のω−３および／またはω−６高度不飽和脂肪酸を含有する極性脂質の豊富な画分の生成および使用
CA2446059C (en) * 2001-05-14 2010-03-23 Martek Biosciences Corporation Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
WO2003053423A2 (en) * 2001-12-18 2003-07-03 The Brigham And Women's Hospital Inhibition or prevention of infection by bacteria with epa, dha or analogs
US7211656B2 (en) 2002-01-30 2007-05-01 Abbott Laboratories Desaturase genes, enzymes encoded thereby, and uses thereof
US7902257B2 (en) * 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
US8481772B2 (en) 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
ITMI20020731A1 (it) * 2002-04-08 2003-10-08 Ibsa Inst Biochimique Sa Composizioni farmaceutiche per acido acetilsalicilico e oli omega-3
KR101138631B1 (ko) 2002-05-22 2012-04-26 몬산토 테크놀로지 엘엘씨 진균 기원의 지방산 데사투라제
EP3584235A3 (de) * 2002-08-12 2020-04-22 Brigham and Women's Hospital Resolvine: biovorlagen für neuartige therapeutische interventionen
US7759395B2 (en) * 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
US7125672B2 (en) * 2003-05-07 2006-10-24 E. I. Du Pont De Nemours And Company Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
US7238482B2 (en) 2003-05-07 2007-07-03 E. I. Du Pont De Nemours And Company Production of polyunsaturated fatty acids in oleaginous yeasts
US7214491B2 (en) * 2003-05-07 2007-05-08 E. I. Du Pont De Nemours And Company Δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
CA2542574C (en) 2003-11-12 2014-03-18 E. I. Du Pont De Nemours And Company Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
MXPA04002940A (es) * 2004-03-26 2005-09-28 Velez Rivera Hector Fitocomposicion para el tratamiento de enfermedades articulares.
WO2005105025A1 (en) * 2004-04-14 2005-11-10 Boston University Methods and compositions for preventing or treating periodontal diseases
CA2563875C (en) 2004-04-22 2015-06-30 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7138391B2 (en) * 2004-08-09 2006-11-21 Silverbrook Research Pty Ltd Hydrophilizable and hydrophilic cyanine dyes
US7465564B2 (en) * 2004-08-10 2008-12-16 E.I. Du Pont De Nemours And Company Production of γ-linolenic acid in oleaginous yeast
US7456270B2 (en) * 2004-09-01 2008-11-25 Abbott Laboratories Δ6-desaturase genes and uses thereof
WO2007041440A2 (en) 2005-10-03 2007-04-12 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers
EP1954291A1 (de) 2005-11-18 2008-08-13 Trustees Of Boston University Behandlung und prävention von knochenschwund mithilfe von resolvinen
US8871808B2 (en) 2006-06-22 2014-10-28 Ben-Gurion University Of The Negev Research And Development Authority Et Al. Over-production of dihomo linolenic acid by a mutant strain of Parietochloris incisa
WO2009022323A1 (en) * 2007-08-13 2009-02-19 Ben-Gurion University Of The Negev Research And Development Authority Over-production of dihomo gamma linolenic acid by a mutant strain of parietochloris incisa
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2009058799A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
EP2358869B1 (de) 2008-10-06 2014-03-26 Abbott Laboratories Delta-8-desaturasegene, von diesen kodierte enzyme und ihre verwendung
US8188335B2 (en) 2009-07-17 2012-05-29 Abbott Laboratories Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
US8952000B2 (en) * 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
MX340951B (es) 2011-09-29 2016-07-29 Plx Pharma Inc Portadores dependientes del ph para la liberacion dirigida de productos farmaceuticos a lo largo del tracto gastrointestinal, composiciones de los mismos, y fabricación y uso de las mismas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
US4328243A (en) * 1981-04-07 1982-05-04 Horrobin David F Manic-depressive illnesses
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels

Also Published As

Publication number Publication date
GB8507058D0 (en) 1985-04-24
DE3669064D1 (de) 1990-03-29
CA1261274A (en) 1989-09-26
IE58712B1 (en) 1993-11-03
IE860616L (en) 1986-09-19
AU5464486A (en) 1986-10-16
EP0195570A3 (en) 1987-10-14
EP0195570B1 (de) 1990-02-21
EP0195570A2 (de) 1986-09-24
JPS61215322A (ja) 1986-09-25
AU584685B2 (en) 1989-06-01
US4666701A (en) 1987-05-19
ZA861774B (en) 1986-11-26

Similar Documents

Publication Publication Date Title
ATE50433T1 (de) Pharmazeutische zusammensetzungen.
US4593044B1 (de)
MY102392A (en) Pharmaceutical products providing enhanced analgesia.
PT85398A (pt) Dispositivo para prender firmemente uma seringa num corpo que pode ser aplicado a mesma
FI872808A7 (fi) Uudet tooppisesti annostettavat farmaseuttiset koostumukset, joilla on systeeminen vaikutus.
CA2100212A1 (en) Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
IT8821324A0 (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
GB8918294D0 (en) Pharmaceutical compositions
FI872638A7 (fi) Parannukset asetyylisalisyylihappo-kuohutableteissa ja niiden suhteen.
KR890003379A (ko) 항-아테롬성 동맥경화제로서의 독사조신
FR2385398B1 (de)
FR2674754B1 (fr) Composition medicamenteuse micronisee.
DE68911501D1 (de) Analgetische antacide Brausezusammensetzung mit reduziertem Natriumgehalt.
ATE69167T1 (de) Pharmazeutische zusammensetzung fuer die prophylaxe und die therapie des magengeschwuers.
KR940701249A (ko) 진통제
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
AU570937B2 (en) Synergistic composition of hydroxyzine and salts thereof with nsaids
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
IE35507L (en) Preparations containing tetrahydrocarbazole¹derivatives
IT1224250B (it) Associzione del depiprazolo con la morfina
DK115789A (da) Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
ATE98484T1 (de) Analgetische antacide brausezusammensetzung mit reduziertem natriumgehalt.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee